| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/05/2007 | US20070154477 Humanized anti-CD3 specific antibodies |
| 07/05/2007 | US20070154451 Enhancer contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter |
| 07/05/2007 | DE102005062440A1 Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen Protein-based carrier system to overcome resistance of tumor cells |
| 07/05/2007 | DE102005054918A1 Pharmaceutically active substance, useful for treating tumor diseases, comprises a non-purified poison aggregate obtained from animals of the species Sicarius, preferably of the species oweni |
| 07/05/2007 | DE102005054909A1 Method for inhibiting cell growth such as tumor, cancer or HIV cells, comprises applying nucleophosmin/B23-binding peptide, for up-regulating p53 transcriptional activity |
| 07/05/2007 | DE102005054688A1 Pharmaceutically active substance, useful to treat tumor diseases, comprises unpurified saliva obtained from animals of the genus Varanus, Timon, Lacerta and/or Podarcis |
| 07/05/2007 | CA2826746A1 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide |
| 07/05/2007 | CA2753405A1 Nitrogen-containing bicyclic heteroaryl compounds and methods of use |
| 07/05/2007 | CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 07/05/2007 | CA2635392A1 New pyrrolic derivatives with histone deacetylase inhibitory activity |
| 07/05/2007 | CA2635375A1 Synergistic effect between a cyanogenic system and another oxidative inducer for the treatment of tumours |
| 07/05/2007 | CA2635127A1 Method for the analysis of differential expression in colorectal cancer |
| 07/05/2007 | CA2634969A1 Controlled release solid preparation |
| 07/05/2007 | CA2634768A1 3-aryl-substituted quinazolones, and uses thereof |
| 07/05/2007 | CA2634746A1 Processes for taxane derivatives and intermediates useful therein |
| 07/05/2007 | CA2633962A1 Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 07/05/2007 | CA2633958A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | CA2632262A1 Method of using .beta.-hydroxy-.beta.-methylbutyrate |
| 07/05/2007 | CA2632256A1 Combination of an iap-inhibitor and a taxane7 |
| 07/05/2007 | CA2631686A1 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate |
| 07/05/2007 | CA2630334A1 Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer |
| 07/05/2007 | CA2628728A1 21-deoxymacbecin analogues useful as antitumor agents |
| 07/04/2007 | EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers |
| 07/04/2007 | EP1803821A2 Methods for managing kinase inhibitor therapy |
| 07/04/2007 | EP1803811A1 Chimeric (double) decoy |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803723A1 (2,4,9-triaza-1(2,4)-pyrimidina-3(1,3)-benzenacyclononaphan-3^4-yl)-sulfoximide derivatives as selective inhibitors of the aurora kinase for the treatment of cancer |
| 07/04/2007 | EP1803711A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 07/04/2007 | EP1803709A1 Proton pump inhibitors |
| 07/04/2007 | EP1803467A1 Composite fine particles and process for producing the same |
| 07/04/2007 | EP1803459A1 Antitumor composition |
| 07/04/2007 | EP1803456A1 Use of non-peptidic nk1 receptor antagonists for the production of apoptosis in tumour cells |
| 07/04/2007 | EP1802660A2 Methods of using death receptor ligands and cd20 antibodies |
| 07/04/2007 | EP1802659A2 Compositions and methods for treatment of non-hodgkin's lymphoma |
| 07/04/2007 | EP1802656A1 Tweak receptor |
| 07/04/2007 | EP1802643A1 Antiviral oligonucleotides |
| 07/04/2007 | EP1802636A1 Pi3 kinases |
| 07/04/2007 | EP1802634A2 Thiophens and their use as anti-tumor agents |
| 07/04/2007 | EP1802633A1 Benzothieno[2,3-d]pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases |
| 07/04/2007 | EP1802626A1 Pyrrolotriazine compounds |
| 07/04/2007 | EP1802625A1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 07/04/2007 | EP1802617A2 Cancer treatment method |
| 07/04/2007 | EP1802614A1 Quinazolinylmethylenethiazolinones as cdk1 inhibitors |
| 07/04/2007 | EP1802610A1 Crystalline form 2 of atrasentan hydrochloride |
| 07/04/2007 | EP1802608A1 Quinazoline derivatives for use against cancer |
| 07/04/2007 | EP1802603A1 Quinoline derivatives |
| 07/04/2007 | EP1802591A1 Quinazoline derivatives |
| 07/04/2007 | EP1802586A2 Heteroaryl-substituted alkyne compounds and method of use |
| 07/04/2007 | EP1802579A1 3-arylamino pyridine derivatives |
| 07/04/2007 | EP1802577A1 Indane amides with antiproliferative activity |
| 07/04/2007 | EP1802339A2 Treating neoplasms with neurotoxin |
| 07/04/2007 | EP1802313A2 Therapeutic agents trageting the ncca-atp channel and methods of use thereof |
| 07/04/2007 | EP1802306A2 Quinolone analog as cell proliferation inhibitors |
| 07/04/2007 | EP1802305A2 Compositions and methods for disruption of brca2-rad51 interaction |
| 07/04/2007 | EP1802295A1 Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof |
| 07/04/2007 | EP1802291A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 07/04/2007 | EP1802274A1 Inhibition of tumour cell migration |
| 07/04/2007 | EP1622896B1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents |
| 07/04/2007 | EP1581484B1 Hydroxamic acid derivatives having anti-inflammatory action |
| 07/04/2007 | EP1523318A4 Treatment of human multiple myeloma by curcumin |
| 07/04/2007 | EP1464636B1 Novel substance having antitumor/anti-inflammatory activity |
| 07/04/2007 | EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
| 07/04/2007 | EP1260512B1 Novel cyclic amide derivatives |
| 07/04/2007 | EP1242823B1 Selecting library members capable of binding to epitopes |
| 07/04/2007 | EP1124982B1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i |
| 07/04/2007 | EP1079851B1 Use of anti-prolactin agents to treat cancer |
| 07/04/2007 | EP1053023B1 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 07/04/2007 | EP1034301B1 Inhibition of an fgf-binding protein using ribozymes |
| 07/04/2007 | EP0977750B1 Farnesyltransferase inhibiting quinazolinones |
| 07/04/2007 | CN2917637Y Precharge preparation of antitumor agent |
| 07/04/2007 | CN1993469A Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
| 07/04/2007 | CN1993466A Method for treating synovial sarcoma using sirna for fzd10 |
| 07/04/2007 | CN1993362A 稠合的杂环化合物 Fused heterocyclic compounds |
| 07/04/2007 | CN1993356A Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 07/04/2007 | CN1993353A Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 07/04/2007 | CN1993351A Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 07/04/2007 | CN1993349A Quinazoline derivatives as ERBB receptor tyrosine kinases |
| 07/04/2007 | CN1993331A N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 07/04/2007 | CN1993318A Bis(thio-hydrazide amide) salts for treatment of cancers |
| 07/04/2007 | CN1993146A Antibody-drug conjugates and methods |
| 07/04/2007 | CN1993130A Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 07/04/2007 | CN1993129A Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 07/04/2007 | CN1993127A Azaindoles modulating c-kit activity and uses therefor |
| 07/04/2007 | CN1990504A Earthworm protein suppressing cancer cell accretion by road spectrum |
| 07/04/2007 | CN1990489A Use of bohnenkraut ethers compounds and compositions thereof |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990485A Silybin flavonolignan and their production method and use |
| 07/04/2007 | CN1990484A Silybin esters derivatives and preparation and use thereof |
| 07/04/2007 | CN1990475A Substituted benzisoselenazolone compounds and use thereof |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1990448A 4, 5 ring-opening diterpene quinone compounds, production method and use thereof |
| 07/04/2007 | CN1990044A Preparation and use of human body immunocompetent cell DCCIK anti-tumor cell preparation |
| 07/04/2007 | CN1990040A Strengthening vaccine kit for treating sarcoma and its application |